Condition
Postoperative Myalgia
Total Trials
5
Recruiting
0
Active
0
Completed
4
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 5 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 4 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
5Total
Not Applicable (3)
P 2 (2)
Trial Status
Completed4
Suspended1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 4 completed trials
Clinical Trials (5)
Showing 5 of 5 trials
NCT03476044Phase 2CompletedPrimary
Effect of Selenium on Succinylcholine-Induced POM
NCT03037073Phase 2CompletedPrimary
Duloxetine for Succinylcholine-induced Postoperative Myalgia
NCT01996358Not ApplicableSuspended
Comparing Intubating Conditions Using Succinylcholine or Rocuronium for Rigid Bronchoscopy
NCT01966484Not ApplicableCompleted
Low Dose Mivacurium vs. Low Dose Succinylcholine for Rigid Bronchoscopy
NCT01902641Not ApplicableCompleted
Muscle Relaxation for Short Procedures
Showing all 5 trials